Mast cell activation syndrome (MCAS) affects more than 15% of the U.S. population but evades most practitioners’ radar. Just five years ago, it wasn’t even on my radar, despite already having 20 years of experience as a clinician at that time. The more I dug (similar to leaky gut and post-COVID syndrome), the more I found my patients were suffering from this disorder.
Sheldon Li, PhD
Dr. Sheldon Li is the chairman of ActiveHerb Technology, Inc. (www.ActiveHerbWholesale.com). He received his PhD in molecular biology with honor from the University of Zurich and conducted cutting-edge research at Yale, UCSD and the Scripps Research Institute. He has made numerous original scientific discoveries, which have been published in prestigious scientific journals like Nature. His seminal discoveries are featured in the Molecular Biology of the Gene, an influential textbook studied by biomedical students in the U.S. and around the world. He sees TCM is undervalued by the mainstream science and now devotes himself to communicating the enormous value of TCM to the public.